Renal Cancer - Results from #5420

K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth December 27, 2016

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics December 27, 2016

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients December 27, 2016

Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues December 23, 2016

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma. December 23, 2016

A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects December 22, 2016

Cancer incidence and survival trends by subtype using data from the Surveillance Epidemiology and End Results Program, 1992-2013 December 22, 2016

Wilms tumor: "State-of-the-art" update, 2016 December 22, 2016

Biology and treatment of renal tumours in childhood December 20, 2016

Sunitinib in kidney cancer: 10 years of experience and development December 20, 2016

Causal inference in obesity research December 19, 2016

Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma December 18, 2016

Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study. December 18, 2016

Adjuvant treatment for renal cell carcinoma: do we finally have a major breakthrough? December 12, 2016

MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity December 9, 2016

Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma December 9, 2016

Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma December 9, 2016

Genetic predisposition to kidney cancer December 8, 2016

The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma December 8, 2016

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness December 8, 2016

Page 272 of 456